logo
Select company
Select metric
73.6%Gross Margin
VS
Market
71
Sector
55
Industry
20
History
40
$ 2.02Close
$ 1.52 - $ 4.62 52-Week Range
Ticker Information

Ticker

MREO

Company Name

MEREO BIOPHARMA GROUP PLC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

MEREO BIOPHARMA GROUP PLC - Gross Margin Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

MREO - Gross % Historical data
DateGross ProfitGross MarginRevenues
6/30/2025$ 368K73.6%$ 500K
3/31/2025$ 00%$ 0
12/31/2024$ 00%$ 0
6/30/2024$ 1.58M145.39%$ 1.09M
12/31/2023$ 7.43M74.26%$ 10M
6/30/2023$ 6.57M73.75%$ 8.91M
12/31/2022$ 1.17M0%$ 0
6/30/2022$ 726.25K0%$ 0
12/31/2021$ 23.2M50.89%$ 45.58M
6/30/2021$ 22.91M50.26%$ 45.58M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • MEREO BIOPHARMA GROUP PLC's latest trailing twelve months (TTM) Gross % stands at 0%.
  • Over the past 5 years, MEREO BIOPHARMA GROUP PLC's average Gross % has been 78.03%.
  • The median Gross % for MEREO BIOPHARMA GROUP PLC during this period was 73.68%
  • MEREO BIOPHARMA GROUP PLC reached its highest Gross % over the past 5 years at 145.39%.
  • The lowest Gross % recorded by MEREO BIOPHARMA GROUP PLC in the same timeframe 50.26%

MEREO BIOPHARMA GROUP PLC's Gross % vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

Gross % Benchmarks
CompanyGross %
CRDF : CARDIFF ONCOLOGY INC 100%ABEO : ABEONA THERAPEUTICS INC 100%HUMA : HUMACYTE INC 55.99%AVTX : AVALO THERAPEUTICS INC 242.18%COYA : COYA THERAPEUTICS INC 100%ABVC : ABVC BIOPHARMA INC 99.92%FDMT : 4D MOLECULAR THERAPEUTICS INC 100%VTGN : VISTAGEN THERAPEUTICS INC 100%ERNA : ERNEXA THERAPEUTICS INC 112.3%ANNX : ANNEXON INC -

Definition of Gross Margin

[Calculation] Gross margin, also called gross profit margin, represents the percentage of total revenue that the company retains after subtracting direct costs associated with producing the goods and services sold by the company [CoR]. Calculated by dividing gross profit [GP] by [Revenue].
GP / Revenues
(=) Gross %
Gross % for MEREO BIOPHARMA GROUP PLC is calculated as follows: GP [ $ 0 ] / Revenues [ $ 0 ]
(=) Gross % [ 0% ]

MREO - Gross Margin, Last 5 years

50.26%

Minimum

Jun 30, 2021

145.39%

Maximum

Jun 30, 2024

78.03%

Average

73.68%

Median

Gross % Benchmark Analysis

The chart above depicts the distribution of Gross % for companies in the Total Stock Market. The average Gross % of the companies is 53.11% with a standard deviation of 31.58%.
The following table provides additional summary stats:
Gross % in the Market:
filtered constituents3.81K
min-72.25%
max150.26%
average53.11%
median49.46%
std31.58%